Back to Search Start Over

UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.

Authors :
Chen, Ya-Xiao
Zhang, Xiao-Jing
Huang, Jia
Zhou, Shu-Jun
Liu, Fang
Jiang, Lin-Lin
Chen, Meiwan
Jian-Bo, Wan
Yang, Dong-Zi
Source :
Journal of Pharmaceutical & Biomedical Analysis. Mar2016, Vol. 121, p141-150. 10p.
Publication Year :
2016

Abstract

Polycystic ovary syndrome (PCOS), characterized with menstrual irregularities, hyperandrogenism and ovulatory abnormalities, is usually companied with insulin resistance (IR) and accounts for one of the most prevalent reproductive dysfunction of premenopausal women. Despite accumulating investigations, diagnostic standards of this pathological condition remain obscure. The aim of present study is to characterize the plasma metabolic characteristics of PCOS patients with and without IR, and subsequently identify the potential biomarkers for the diagnosis of PCOS and its IR complication. A total of 59 plasma samples from eligible healthy controls (CON, n = 19), PCOS patients without IR (non-IR PCOS, n = 19) and PCOS patients with IR (IR PCOS, n = 21) were profiled by an ultra high-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC/Q-TOFMS) followed by multivariate statistical analysis. Compared to the healthy controls, significant decrease in the levels of phosphocholines (PCs) and lyso PC (18:2), and increase in trilauric glyceride level were observed in the plasma of IR PCOS. Meanwhile, the significant increase in the levels of saturated fatty acids (palmitic acid and stearic acid) and decanoylcarnitine, and decrease in PC (36:2) and PS (36:0) were found in non-IR PCOS patients. Trilauric glyceride and decanoylcarnitine were identified as the potential biomarkers with the highest sensitivity and specificity for the diagnosis of PCOS patients with and without IR, respectively. Furthermore, based on these alterations of metabolites, MetPA network pathway analysis suggested a profound involvement of the abnormalities of glycerophospholipid, glycerolipid and fatty acid metabolisms in the pathogenesis of PCOS and IR complications. Collectively, LC–MS-based metabolomics provides a promising strategy for complementary diagnosis of PCOS and its IR complication and offers a new insight to understand their pathogenesis mechanisms. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
07317085
Volume :
121
Database :
Academic Search Index
Journal :
Journal of Pharmaceutical & Biomedical Analysis
Publication Type :
Academic Journal
Accession number :
113104474
Full Text :
https://doi.org/10.1016/j.jpba.2016.01.025